Shoji Mitsufuji Selected Research

Shoji Mitsufuji Research Topics

Disease

7	Neoplasms (Cancer) 02/2010 - 01/2002
4	Infections 12/2008 - 10/2004
4	Inflammation (Inflammations) 12/2008 - 03/2004
4	Pancreatitis 05/2008 - 03/2004
3	Stomach Neoplasms (Stomach Cancer) 02/2010 - 02/2002
3	Hemorrhage 01/2010 - 04/2004
3	Fistula 12/2008 - 01/2003
2	Polyps 03/2019 - 09/2005
2	Pathologic Constriction (Stenosis) 02/2013 - 07/2005
2	Edema (Dropsy) 02/2013 - 03/2004
2	Varicose Veins (Varicose Vein) 01/2010 - 07/2009
2	Esophageal Neoplasms (Esophageal Cancer) 10/2005 - 01/2003
2	Pathologic Complete Response 10/2005 - 07/2005
2	Carcinoma (Carcinomatosis) 09/2005 - 12/2004
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 07/2005 - 03/2004
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 12/2004 - 01/2002
2	Diarrhea 11/2004 - 03/2004
2	Colitis 03/2004 - 05/2002
1	Eosinophilic enteropathy 02/2013
1	Cicatrix (Scar) 02/2013
1	Ulcer 02/2013
1	Hemophilia A (Haemophilia) 01/2010
1	Idiopathic Noncirrhotic Portal Hypertension 07/2009
1	Hepatocellular Carcinoma (Hepatoma) 02/2009
1	Nematode Infections 11/2008
1	Hyperplasia 11/2008
1	Hematologic Neoplasms (Hematological Malignancy) 08/2008
1	Gastrointestinal Hemorrhage (Hematochezia) 08/2008
1	Reinfection 05/2008
1	Mumps 05/2008
1	Citrullinemia 02/2008
1	Non-alcoholic Fatty Liver Disease 02/2008
1	Rupture 01/2007
1	Pseudomyxoma Peritonei 01/2007
1	Abscess 07/2006
1	Reperfusion Injury 04/2006
1	Genetic Translocation (Chromosomal Translocation) 02/2006
1	Lymphoma (Lymphomas) 02/2006
1	Carcinogenesis 12/2005
1	Tracheoesophageal Fistula 10/2005
1	Lymphatic Metastasis 10/2005
1	Deglutition Disorders (Dysphagia) 10/2005

Drug/Important Bio-Agent (IBA)

4	EnzymesIBA 05/2008 - 09/2004
3	Proteins (Proteins, Gene)FDA Link 12/2008 - 11/2004
3	Amylases FDA Link 05/2008 - 01/2005
3	CeruletideIBA 08/2006 - 03/2004
3	ParaffinIBA 02/2006 - 09/2004
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2006 - 01/2005
2	Peroxidase (Myeloperoxidase)IBA 08/2006 - 01/2005
2	Anti-Bacterial Agents (Antibiotics)IBA 07/2006 - 03/2004
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2005 - 03/2004
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2004 - 01/2002
2	GlucocorticoidsIBA 03/2004 - 05/2002
1	Castor Oil (Oil, Castor)IBA 03/2019
1	Capsules (Microcapsules)IBA 02/2013
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 02/2010
1	tissue-factor-pathway inhibitor 2 (PP5)IBA 02/2010
1	MethyltransferasesIBA 02/2010
1	Decitabine FDA Link 02/2010
1	Factor VIII (Coagulation Factor VIII)IBA 01/2010
1	AlbuminsIBA 09/2009
1	Serum AlbuminIBA 09/2009
1	Iopamidol (Isovue)FDA LinkGeneric 07/2009
1	ethanolamine oleate (Ethamolin)FDA Link 07/2009
1	OligonucleotidesIBA 02/2009
1	DNA (Deoxyribonucleic Acid)IBA 02/2009
1	Urethane (Ethyl Carbamate)IBA 12/2008
1	Interleukin-17 (Interleukin 17)IBA 12/2008
1	SialomucinsIBA 11/2008
1	Polysaccharides (Glycans)IBA 11/2008
1	SulfotransferasesIBA 11/2008
1	galactose-3-O-sulfotransferase 3IBA 11/2008
1	sulfomucinIBA 11/2008
1	Interleukin-18 (Interleukin 18)IBA 06/2008
1	Immunoglobulin G (IgG)IBA 05/2008
1	Immunoglobulin M (IgM)IBA 05/2008
1	ImmunosorbentsIBA 05/2008
1	Lipase (Acid Lipase)FDA Link 05/2008
1	AmmoniaIBA 02/2008
1	CitrullineIBA 02/2008
1	IsoenzymesIBA 08/2006
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 08/2006
1	Vasodilator Agents (Vasodilators)IBA 08/2006
1	Tight Junction ProteinsIBA 04/2006
1	Claudin-1IBA 04/2006
1	Claudin-2IBA 04/2006
1	Claudin-4IBA 04/2006
1	Fluorescein (Funduscein)FDA LinkGeneric 04/2006
1	OccludinIBA 04/2006
1	A-factor (Streptomyces)IBA 12/2005
1	Keratin-20 (Cytokeratin 20)IBA 09/2005

Therapy/Procedure

6	Therapeutics 10/2005 - 01/2004
2	Sclerotherapy 01/2010 - 07/2009
2	Drug Therapy (Chemotherapy) 08/2008 - 03/2004
2	Transplantation 01/2005 - 04/2004
1	Anesthesia 12/2008
1	Appendectomy 01/2007
1	Subcutaneous Injections 08/2006
1	Palliative Care (Palliative Therapy) 10/2005
1	Self Expandable Metallic Stents 10/2005